Application of the linear-quadratic model to combined modality radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 1, 2004, Pages 228-241

  Bodey, Rachel K ^a   Evans, Phil M ^a   Flux, Glenn D ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Biologically effective dose; Combined modality radiotherapy; External beam radiotherapy; Linear quadratic model; Targeted radionuclide therapy

Indexed keywords

APPROXIMATION THEORY; DISEASE CONTROL; PARAMETER ESTIMATION; PATIENT MONITORING; POISSON DISTRIBUTION; RADIOISOTOPES; RADIOTHERAPY; TUMORS;

EXTERNAL BEAM THERAPY (EBT); MODALITY; RADIOBIOLOGIC EFFECT; TUMOR CONTROL;

ONCOLOGY;

ARTICLE; CANCER RADIOTHERAPY; DOSIMETRY; MATHEMATICAL COMPUTING; MULTIMODALITY CANCER THERAPY; PREDICTION; PRIORITY JOURNAL; PROBABILITY; SPINAL CORD; TUMOR MODEL;

COMBINED MODALITY THERAPY; LINEAR MODELS; NEOPLASMS; RADIOISOTOPES; RELATIVE BIOLOGICAL EFFECTIVENESS; REPRODUCIBILITY OF RESULTS;

EID: 13844303055     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.12.031     Document Type: Article

References (45)

1. Bodey R.K., Flux G.D., Evans P.M. Combining dosimetry for targeted radionuclide and external beam therapies using the biologically effective dose. Cancer Biother Radiopharm. 18:2003;89-97.
2. Barendsen G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 8:1982;1981-1997.
3. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 62:1989;679-694.
4. Joiner MC, Bentzen SM. Time-dose relationships: The linear-quadratic approach. In: Steel GG, editor. Basic clinical radiobiology. London: Arnold; 2002. p. 120-133.
5. Thames H.D. An 'incomplete-repair' model for survival after fractionated and continuous irradiations. Int J Radiat Biol Relat Stud Phys Chem Med. 47:1985;319-339.
6. Dale R.G. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol. 58:1985;515-528.
7. Millar W.T. Application of the linear-quadratic model with incomplete repair to radionuclide directed therapy. Br J Radiol. 64:1991;242-251.
8. Dale R.G. Dose-rate effects in targeted radiotherapy. Phys Med Biol. 41:1996;1871-1884.
9. Nilsson P., Thames H.D., Joiner M.C. A generalized formulation of the 'incomplete-repair' model for cell survival and tissue response to fractionated low dose-rate irradiation. Int J Radiat Biol. 57:1990;127-142.
10. Brenner D.J., Hlatky L.R., Hahnfeldt P.J., et al. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships. Radiat Res. 150:1998;83-91.
11. Sachs R.K., Hahnfeld P., Brenner D.J. The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair. Int J Radiat Biol. 72:1997;351-374.
12. Lea DE, Catcheside DG. The mechanism of the induction by radiation of chromosome aberrations in tradescantia. J Genet 1942;44:216-245.
13. Wheldon T.E., O'Donoghue J.A. The radiobiology of targeted radiotherapy. Int J Radiat Biol. 58:1990;1-21.
14. Chapman J.D. Single-hit mechanism of tumour cell killing by radiation. Int J Radiat Biol. 79:2003;71-81.
15. Joiner M.C., Bremner J.C., Denekamp J., et al. The interaction between X-rays and 3 MeV neutrons in the skin of the mouse foot. Int J Radiat Biol Relat Stud Phys Chem Med. 46:1984;625-638.
16. Zaider M., Rossi H.H. The synergistic effects of different radiations. Radiat Res. 83:1980;732-739.
17. Nahum A.E., Tait D.M. Maximising control by customised dose prescription for pelvic tumours. Breit A. Advanced radiation therapy: tumour response monitoring and treatment planning. 1992;425-431 Springer, Heidelberg.
18. Niemierko A., Goitein M. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother Oncol. 29:1993;140-147.
19. Goitein M., Niemierko A., Okunieff P. The probability of controlling an inhomogeneously irradiated tumour: A stratagem for improving tumour control through partial tumour boosting. Faulkner K. Proceedings of 19th L H Gray Conference, Newcastle (1995). 1996;25-39 British Institute of Radiology, London.
20. Webb S., Nahum A.E. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol. 38:1993;653-666.
21. Deacon J., Peckham M.J., Steel G.G. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol. 2:1984;317-323.
22. Thames H.D., Bentzen S.M., Turesson I., et al. Fractionation parameters for human tissues and tumors. Int J Radiat Biol. 56:1989;701-710.
23. Fowler J.F. Dose rate effects in normal tissues. Mould R.F. Brachytherapy 2, Proceedings of Brachytherapy Working Conference 5th International Selectron Users Meeting. 1988;26-40 Nucletron International, The Netherlands.
24. Liversage W.E. A general formula for equating protracted and acute regimes of radiation. Br J Radiol. 42:1969;432-440.
25. Thames H.D. Jr., Withers H.R., Peters L.J. Tissue repair capacity and repair kinetics deduced from multifractionated or continuous irradiation regimens with incomplete repair. Br J Cancer. 6:(Suppl VI):1984;263-269.
26. Steel G.G. Recovery kinetics deduced from continuous low dose-rate experiments. Radiother Oncol. 14:1989;337-343.
27. Brenner D.J., Hall E.J. Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy. Int J Radiat Oncol Biol Phys. 20:1991;181-190.
28. Thames H.D., Ang K.K., Stewart F.A., et al. Does incomplete repair explain the apparent failure of the basic LQ model to predict spinal cord and kidney responses to low doses per fraction? Int J Radiat Biol. 54:1988;13-19.
29. Ruifrok A.C., Kleiboer B.J., van der Kogel A.J. Fractionation sensitivity of the rat cervical spinal cord during radiation retreatment. Radiother Oncol. 25:1992;295-300.
30. Pop L.A., van der P.M., Skwarchuk M.W., et al. High dose rate (HDR) and low dose rate (LDR) interstitial irradiation (IRT) of the rat spinal cord. Radiother Oncol. 42:1997;59-67.
31. Ang K.K., Jiang G.L., Guttenberger R., et al. Impact of spinal cord repair kinetics on the practice of altered fractionation schedules. Radiother Oncol. 25:1992;287-294.
32. Landuyt W., Fowler J., Ruifrok A., et al. Kinetics of repair in the spinal cord of the rat. Radiother Oncol. 45:1997;55-62.
33. Pop L.A., Millar W.T., van der P.M., et al. Radiation tolerance of rat spinal cord to pulsed dose rate (PDR-) brachytherapy The impact of differences in temporal dose distribution. Radiother Oncol. 55:2000;301-315.
34. Scalliet P., Landuyt W., Van der S.E. Repair kinetics as a determining factor for late tolerance of central nervous system to low dose rate irradiation. Radiother Oncol. 14:1989;345-353.
35. Ruifrok A.C., Kleiboer B.J., van der Kogel A.J. Repair kinetics of radiation damage in the developing rat cervical spinal cord. Int J Radiat Biol. 63:1993;501-508.
36. Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 43:1999;1095-1101.
37. Nahum A.E., Movsas B., Horwitz E.M., et al. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer Implications for the alpha/beta ratio. Int J Radiat Oncol Biol Phys. 57:2003;391-401.
38. Brenner D.J., Martinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys. 52:2002;6-13.
39. Fowler J., Chappell R., Ritter M. Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys. 50:2001;1021-1031.
40. Wang J.Z., Guerrero M., Li X.A. How low is the alpha/beta ratio for prostate cancer? Int J Radiat Oncol Biol Phys. 55:2003;194-203.
41. Johansson M., Bergenheim A.T., Widmark A., et al. Effects of radiotherapy and estramustine on the microvasculature in malignant glioma. Br J Cancer. 80:1999;142-148.
42. Sonveaux P., Dessy C., Brouet A., et al. Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene delivery. FASEB J. 16:2002;1979-1981.
43. Blumenthal R.D., Sharkey R.M., Kashi R., et al. Changes in tumor vascular permeability in response to experimental radioimmunotherapy A comparative study of 11 xenografts. Tumour Biol. 18:1997;367-377.
44. Blumenthal R.D., Kashi R., Sharkey R.M., et al. Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeability. Int J Cancer. 61:1995;557-566.
45. Cohen F.M., Kuwatsuru R., Shames D.M., et al. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation. Invest Radiol. 29:1994;970-977.